Pål Kristian Selbo

Oslo University Hospital — Norway

Medicine · Health Sciences

35h-index4.0kcitations102works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Photodynamic Therapy Research Studies(61), Nanoplatforms for cancer theranostics(37), RNA Interference and Gene Delivery(16), Immunotherapy and Immune Responses(14), Toxin Mechanisms and Immunotoxins(14)

Publications102 total

Light-enhanced cytotoxicity and intracellular trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab
Biomedicine & Pharmacotherapy·2025Open Access
3117eP ERBB3-altered clinically advanced urothelial bladder cancer: Genomic landscape study and therapeutic possibilities
Annals of Oncology·2025Open Access
Circulating kidney injury molecule-1 (KIM-1) and association with outcome to adjuvant immunotherapy in renal cell carcinoma
Annals of Oncology·2025· 6 citedOpen Access
Inflammatory Cutaneous Reactions with Systemic CD8+ T-Cell Responses upon Photochemical Internalization of Antigens in Mice
Journal of Investigative Dermatology·2025Open Access
A0659 – Outcomes of immune-checkpoint inhibitor rechallenge in urothelial carcinoma: Results from a global real-world evidence study
European Urology·2025Open Access
Enhancing antitumour immunity with photodynamic therapy
Photochemical & Photobiological Sciences·2025· 8 citedOpen Access
Photochemical internalisation to enhance pancreatic cancer chemotherapy
Pancreatology·2024
Abstract A027: Enhancing pancreatic cancer chemotherapy through photochemical internalisation
Cancer Research·2024· 1 cited
Topical collection on photodynamic therapy-enhanced antitumour immunity
Photochemical & Photobiological Sciences·2024· 1 citedOpen Access
287MO Real-world experience with maintenance PARP inhibitor plus minus bevacizumab in newly diagnosed advanced ovarian cancer with germline BRCA mutations or homologous recombination deficiency (HRD) positive
Annals of Oncology·2023Open Access
244P Clinicopathologic feature and treatment outcome of metastatic non clear cell kidney cancer: A single centre experience from India
Annals of Oncology·2023Open Access
All-trans retinoic acid enhances the anti-tumour effects of fimaporfin-based photodynamic therapy
Biomedicine & Pharmacotherapy·2022· 4 citedOpen Access
1383P Genomic landscape of advanced prostate cancer patients with BRCA1 versus BRCA2 mutations as detected by comprehensive genomic profiling (CGP) of cell-free DNA (cfDNA)
Annals of Oncology·2022Open Access
All- <i>trans</i> retinoic acid enhances the anti-tumour effects of fimaporfin-based photodynamic therapy
2022Open Access
Photochemical Internalization of Gemcitabine Is Safe and Effective in Locally Advanced Inoperable Cholangiocarcinoma
The Oncologist·2022· 11 citedOpen Access
Inhibiting autophagy increases the efficacy of low-dose photodynamic therapy
Biochemical Pharmacology·2021· 5 citedOpen Access
Light-controlled elimination of PD-L1+ cells
Journal of Photochemistry and Photobiology B Biology·2021· 9 citedOpen Access
A randomized, double-blind, placebo-controlled, phase 3 trial of infigratinib as adjuvant therapy in patients with invasive urothelial carcinoma harboring susceptible FGFR3 genetic alterations: PROOF 302
European Urology Open Science·2021Open Access
Light-controlled elimination of PD-L1+ cells
2021Open Access
Efficacy and Selectivity of FGF2-Saporin Cytosolically Delivered by PCI in Cells Overexpressing FGFR1
Cells·2021· 2 citedOpen Access
page 1 of 6Next →

Frequent Co-authors

Kristian Berg(39), Anders Høgset(27), Anette Weyergang(23), Lina Prasmickaite(11), Monica Bostad(8), Cathrine Elisabeth Olsen(8), Anette Bonsted(6), Birgit Engesæter(5), Qian Peng(5), Ole-Jacob Norum(4), Gunhild M. Mælandsmo(4), Stephen G. Bown(4), Victoria Edwards(4), Ellen Skarpen(4), Monika Håkerud(4), Kirsten Sandvig(3), Gowsala Sivam(3), Marit Hellum(3), Michael G. Rosenblum(3), Thomas M. Kündig(3)